AI-generated analysis. Always verify with the original filing.
SBC Medical Group Holdings Incorporated announced its fourth quarter and full year 2025 financial results, reporting a 117% year-over-year increase in Q4 net income to $14 million and a 9% increase in full-year net income to $51 million, while revenues declined due to business restructuring and revised franchise fee arrangements.
Event Type
Disclosure
Mandatory
Variant
8-K
, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or oth
shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that section and shall not be deemed t
Other Events. On March 27, 2026, in connection with the Company’s announcements described in this Current Report on Form 8-K, the Company announced certain upda
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated March 27, 2026, entitled “SBC Medical Group Holdings Announce
| Metric | Value | Basis |
|---|---|---|
| Total revenues | $40.00 | GAAP |
| Net Income attributable to SBC Medical Group | $14.00 | GAAP |
| Earnings per share | $0.14 | GAAP |
| EBITDA | $14.00 | Non-GAAP |
| EBITDA margin | 34% | Non-GAAP |